Skip to main content
Clinical Trials/CTRI/2020/11/029132
CTRI/2020/11/029132
Completed
Phase 3

Rotational Thromboelastometry( ROTEM) Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

ILBS hospital0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K740- Hepatic fibrosis
Sponsor
ILBS hospital
Enrollment
60
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 28, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ILBS hospital

Eligibility Criteria

Inclusion Criteria

  • Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR ââ?°Â¥ 1\.5\- ââ?°Â¤ 2\.5 and/or PLT count 20,000/mm3\- 50,000/mm3 and who are listed for the following invasive procedures :
  • Low risk of bleeding
  • Central venous cannulation
  • Haemodialysis catheter
  • Ascitic or Pleural tapping
  • High risk of bleeding
  • ERCP with sphicterotomy
  • PCD Insertion
  • Biopsies other than liver biopsy
  • Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR ââ?°Â¥ 1\.5\- ââ?°Â¤ 2\.0 and/or PLT count 40,000/mm3\- 60,000/mm3 and who are listed for Liver biopsy

Exclusion Criteria

  • Anti platelet or anti coagulant therapy in the previous 7 days
  • Patients with clinical evidence of DIC and/or active bleeding
  • Hemodialysis in the past 7 days

Outcomes

Primary Outcomes

Not specified

Similar Trials